| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | 0.076 | 0.03 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.13 | 0.03 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.03 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.065 | 0.03 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.03 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.071 | 0.03 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.075 | 0.03 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.078 | 0.03 |